We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-1.27%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$283B
AUM Growth
+$27.4B
Cap. Flow
+$30.5B
Cap. Flow %
10.78%
Top 10 Hldgs %
36.77%
Holding
11,338
New
1,654
Increased
4,102
Reduced
3,903
Closed
1,507

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.35%
2 Technology 1.76%
3 Financials 1%
4 Communication Services 0.83%
5 Healthcare 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBRA icon
8926
Sabra Healthcare REIT
SBRA
$5.37B
$163K ﹤0.01%
11,049
-2,532
-19% -$42.8K
DSKE
8927
DELISTED
Daseke, Inc. Common Stock
DSKE
$163K ﹤0.01%
17,702
-193
-1% -$1.6K
MIRO
8928
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$163K ﹤0.01%
23,483
-16,358
-41% -$154K
IPOD.WS
8929
DELISTED
Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOD.WS
$163K ﹤0.01%
93,018
-1,448
-2% -$2.73K
RRD
8930
PUT
DELISTED
RR Donnelley & Sons Co.
RRD
$163K ﹤0.01%
31,800
-90,800
-74% -$484K
CTRM icon
8931
CALL
Castor Maritime
CTRM
$19.7M
$162K ﹤0.01%
+6,640
New +$149K
HOPE icon
8932
Hope Bancorp
HOPE
$1.79B
$162K ﹤0.01%
11,202
-24,709
-69% -$337K
IAG icon
8933
CALL
IAMGOLD
IAG
$10.5B
$162K ﹤0.01%
71,700
+18,200
+34% +$45.4K
CONXW
8934
DELISTED
CONX Corp. Warrant
CONXW
$162K ﹤0.01%
140,698
+461
+0.3% +$536
VIEWW
8935
DELISTED
View, Inc. Warrant
VIEWW
$162K ﹤0.01%
178,461
-157
-0.1% -$173
CPTK.U
8936
DELISTED
Crown PropTech Acquisitions Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CPTK.U
$162K ﹤0.01%
16,488
+302
+2% +$2.99K
ATNX
8937
PUT
DELISTED
Athenex, Inc. Common Stock
ATNX
$162K ﹤0.01%
2,685
-1,095
-29% -$79.7K
ENIA
8938
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$162K ﹤0.01%
+27,655
New +$185K
NEWP
8939
New Pacific Metals
NEWP
$1.17B
$161K ﹤0.01%
+48,576
New +$183K
EMBKW
8940
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$161K ﹤0.01%
150,871
+160
+0.1% +$203
PRVB
8941
CALL
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$161K ﹤0.01%
25,100
-70,300
-74% -$452K
APYX icon
8942
Apyx Medical
APYX
$171M
$160K ﹤0.01%
11,554
-20,066
-63% -$211K
WGS icon
8943
PUT
GeneDx Holdings
WGS
$2.3B
$160K ﹤0.01%
639
+312
+95% +$107K
GHY
8944
PGIM Global High Yield Fund
GHY
$483M
$159K ﹤0.01%
+10,350
New +$163K
ORIO
8945
Orion Digital Corp
ORIO
$15.3M
$159K ﹤0.01%
12,291
+2,307
+23% +$38.3K
PLX icon
8946
CALL
Protalix BioTherapeutics
PLX
$198M
$159K ﹤0.01%
119,600
-51,600
-30% -$78.4K
BLUA.U
8947
DELISTED
BlueRiver Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary shares
BLUA.U
$159K ﹤0.01%
15,988
VEDL
8948
PUT
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$159K ﹤0.01%
10,400
-7,700
-43% -$121K
LCTX icon
8949
Lineage Cell Therapeutics
LCTX
$278M
$158K ﹤0.01%
62,549
-165,517
-73% -$425K
MBI icon
8950
PUT
MBIA
MBI
$260M
$158K ﹤0.01%
+12,300
New +$142K

Similar funds

Jane Street's Q3 2021 Portfolio in Review

As of Q3 2021, Jane Street held 11,338 positions worth $283B, up 11% from $256B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jane Street deployed $30.5B of net new capital in Q3 2021, opening 1,654 new positions and adding to 4,102 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.3% of assets, down from 2.5% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MBS ETF, an estimated $1.01B trimmed.

  • Jane Street's largest Q3 2021 buy was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.64B increase.
  • Jane Street's biggest Q3 2021 reduction was iShares MBS ETF, cutting an estimated $1.01B.
  • Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2021, selling an estimated $338M.
  • Jane Street's ten largest holdings make up 37% of its $283B portfolio in Q3 2021.
  • Jane Street opened 1,654 new positions and closed 1,507 in Q3 2021.
  • Jane Street's portfolio value rose 11% quarter-over-quarter to $283B.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.